HBIO
Price
$0.40
Change
+$0.01 (+2.56%)
Updated
Apr 11 closing price
Capitalization
184.01M
31 days until earnings call
KIDS
Price
$21.16
Change
-$0.23 (-1.08%)
Updated
Apr 11 closing price
Capitalization
686.7M
18 days until earnings call
Ad is loading...

HBIO vs KIDS

Header iconHBIO vs KIDS Comparison
Open Charts HBIO vs KIDSBanner chart's image
Harvard Bioscience
Price$0.40
Change+$0.01 (+2.56%)
Volume$278.78K
Capitalization184.01M
OrthoPediatrics
Price$21.16
Change-$0.23 (-1.08%)
Volume$142.01K
Capitalization686.7M
HBIO vs KIDS Comparison Chart
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KIDS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. KIDS commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and KIDS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (HBIO: $0.40 vs. KIDS: $21.16)
Brand notoriety: HBIO and KIDS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HBIO: 76% vs. KIDS: 60%
Market capitalization -- HBIO: $184.01M vs. KIDS: $686.7M
HBIO [@Medical Specialties] is valued at $184.01M. KIDS’s [@Medical Specialties] market capitalization is $686.7M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileKIDS’s FA Score has 1 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • KIDS’s FA Score: 1 green, 4 red.
According to our system of comparison, both HBIO and KIDS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 5 TA indicator(s) are bullish while KIDS’s TA Score has 5 bullish TA indicator(s).

  • HBIO’s TA Score: 5 bullish, 2 bearish.
  • KIDS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HBIO is a better buy in the short-term than KIDS.

Price Growth

HBIO (@Medical Specialties) experienced а -0.07% price change this week, while KIDS (@Medical Specialties) price change was -6.78% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.20%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was -3.81%.

Reported Earning Dates

HBIO is expected to report earnings on Aug 06, 2025.

KIDS is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (-0.20% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KIDS($687M) has a higher market cap than HBIO($184M). KIDS YTD gains are higher at: -8.714 vs. HBIO (-81.043). HBIO has higher annual earnings (EBITDA): 8.03M vs. KIDS (-8.38M). KIDS has more cash in the bank: 80.3M vs. HBIO (4.28M). KIDS has less debt than HBIO: KIDS (10.1M) vs HBIO (42.8M). KIDS has higher revenues than HBIO: KIDS (149M) vs HBIO (112M).
HBIOKIDSHBIO / KIDS
Capitalization184M687M27%
EBITDA8.03M-8.38M-96%
Gain YTD-81.043-8.714930%
P/E RatioN/A232.56-
Revenue112M149M75%
Total Cash4.28M80.3M5%
Total Debt42.8M10.1M424%
FUNDAMENTALS RATINGS
HBIO vs KIDS: Fundamental Ratings
HBIO
KIDS
OUTLOOK RATING
1..100
7253
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9291
PRICE GROWTH RATING
1..100
9880
P/E GROWTH RATING
1..100
24
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KIDS's Valuation (91) in the Medical Specialties industry is in the same range as HBIO (99) in the Biotechnology industry. This means that KIDS’s stock grew similarly to HBIO’s over the last 12 months.

KIDS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as HBIO (100) in the Biotechnology industry. This means that KIDS’s stock grew similarly to HBIO’s over the last 12 months.

KIDS's SMR Rating (91) in the Medical Specialties industry is in the same range as HBIO (92) in the Biotechnology industry. This means that KIDS’s stock grew similarly to HBIO’s over the last 12 months.

KIDS's Price Growth Rating (80) in the Medical Specialties industry is in the same range as HBIO (98) in the Biotechnology industry. This means that KIDS’s stock grew similarly to HBIO’s over the last 12 months.

HBIO's P/E Growth Rating (2) in the Biotechnology industry is in the same range as KIDS (4) in the Medical Specialties industry. This means that HBIO’s stock grew similarly to KIDS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HBIOKIDS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 5 days ago
71%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 27 days ago
73%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KIDS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBTIX11.390.26
+2.34%
Bridge Builder Tax Managed Intl Eq
ARSYX13.47N/A
N/A
AB Global Real Estate Investment Advisor
HGICX42.17N/A
N/A
Hartford Core Equity C
JDEZX13.06N/A
N/A
PGIM Jennison Global Equity Income Z
JABIX11.09N/A
N/A
JHancock Real Estate Securities R6

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with RVTY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
+3.71%
RVTY - HBIO
48%
Loosely correlated
+1.98%
CRL - HBIO
46%
Loosely correlated
-0.20%
QTRX - HBIO
46%
Loosely correlated
+8.11%
MASI - HBIO
45%
Loosely correlated
+1.59%
IQV - HBIO
44%
Loosely correlated
+1.63%
More

KIDS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KIDS has been loosely correlated with XRAY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KIDS jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KIDS
1D Price
Change %
KIDS100%
-1.08%
XRAY - KIDS
43%
Loosely correlated
+0.95%
HBIO - KIDS
40%
Loosely correlated
+3.71%
ALGN - KIDS
39%
Loosely correlated
+2.50%
SIBN - KIDS
39%
Loosely correlated
+0.91%
AORT - KIDS
38%
Loosely correlated
-0.68%
More